Omnipaque (GE Healthcare)
Welcome to the PulseAid listing for the Omnipaque drug offered from GE Healthcare. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GE Healthcare |
| NON-PROPRIETARY NAME: | Iohexol |
| SUBSTANCE NAME: | IOHEXOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-12-21 |
| END MARKETING DATE: | 0000-00-00 |
Omnipaque HUMAN PRESCRIPTION DRUG Details:
| Item Description | Omnipaque from GE Healthcare |
| LABELER NAME: | GE Healthcare |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/mL) |
| START MARKETING DATE: | 2016-12-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0407-1413_e595cf94-d4a9-40e3-9c20-6fbbe22f8c90 |
| PRODUCT NDC: | 0407-1413 |
| APPLICATION NUMBER: | NDA020608 |
Other IOHEXOL Pharmaceutical Manufacturers / Labelers:
